Latest Articles
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post
Published: Jan. 21, 2025, 4:36 a.m.
Mapping Human Uterine Disorders Through Single-Cell Transcriptomics.
Disruptions in uterine tissue function contribute to disorders such as endometriosis, adenomyosis, endometrial cancer, and fibroids, which all significantly impact health and fertility. Advances in transcriptomics, particularly single-cell RNA sequencing, …
Published: Jan. 21, 2025, midnight
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer - OncLive
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer OncLive
Published: Jan. 20, 2025, 9:34 p.m.
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer - Cancer Network
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer Cancer Network
Published: Jan. 20, 2025, 5:08 p.m.
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use PMLiVE
Published: Jan. 20, 2025, 12:33 p.m.
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment - DirectorsTalk Interviews
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment DirectorsTalk Interviews
Published: Jan. 20, 2025, 7:28 a.m.
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment - TipRanks
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment TipRanks
Published: Jan. 20, 2025, 7:19 a.m.
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer - FirstWord Pharma
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer FirstWord Pharma
Published: Jan. 20, 2025, 7:14 a.m.
Evaluating the association between lipidome and female reproductive diseases through comprehensive Mendelian randomization analyses.
This study aimed to assess the causal relationship between lipidome and female reproductive diseases (FRDs) using an advanced series of Mendelian randomization (MR) methods. This study utilized genome-wide association study …
Published: Jan. 19, 2025, midnight
Prognostic significance of right subdiaphragmatic washing cytology in patients with endometrial cancer - Nature.com
Prognostic significance of right subdiaphragmatic washing cytology in patients with endometrial cancer Nature.com
Published: Jan. 18, 2025, 3:36 a.m.
Link copied to clipboard!